Literature DB >> 24781433

Higher sweat chloride levels in patients with asthma: a case-control study.

Shally Awasthi1, Pratibha Dixit, Nutan Maurya.   

Abstract

OBJECTIVES: To screen asthmatic patients by sweat chloride test to identify proportion with Cystic Fibrosis (CF); (Sweat chloride level >60 mmol/L). Also, to compare sweat chloride levels between cases of bronchial asthma and age and sex matched healthy children aged 5 mo-15 y.
METHODS: The present case-control study was conducted in a tertiary care hospital in India. Cases of bronchial asthma, diagnosed by GINA guideline 2008, and age matched healthy controls were included. Case to control ratio was 2:1. Sweat Chloride test was done by Pilocarpine Iontophoresis method.
RESULTS: From April 2010 through May 2012, 216 asthmatics and 112 controls were recruited. Among asthmatics, there was no case of Cystic Fibrosis. Mean sweat chloride levels in asthmatics was 22.39 ± 8.45 mmol/L (inter-quartile range - 15-28 mmol/L) and in controls 19.55 ± 7.04 mmol/L (inter-quartile range - 15-23.5 mmol/L) (p value = 0.048).
CONCLUSIONS: No Cystic Fibrosis case was identified among asthmatics. Mean sweat chloride levels were higher in asthmatics as compared to controls.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24781433     DOI: 10.1007/s12098-014-1432-5

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  19 in total

Review 1.  The pathogenic consequences of a single mutated CFTR gene.

Authors:  U Griesenbach; D M Geddes; E W Alton
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Australian guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis: report from the AACB Sweat Testing Working Party.

Authors:  John Coakley; Sue Scott; James Doery; Ronda Greaves; Peter Talsma; Elaine Whitham; Janet Winship
Journal:  Clin Biochem Rev       Date:  2006-05

Review 3.  Guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis.

Authors:  Anne Green; Jean Kirk
Journal:  Ann Clin Biochem       Date:  2007-01       Impact factor: 2.057

4.  Molecular basis of cystic fibrosis disease: an Indian perspective.

Authors:  R Prasad; H Sharma; G Kaur
Journal:  Indian J Clin Biochem       Date:  2010-11-19

5.  Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men.

Authors:  A G Leitch; L J Clancy; J F Costello; D C Flenley
Journal:  Br Med J       Date:  1976-02-14

6.  Sweat test in asthmatic children; a single center study.

Authors:  Bahram Mirsaeid Ghazi; Roya Khalesi; Mohsen Naseri; Payman Salamati; Kambiz Sotoudeh; Nima Rezaei
Journal:  Iran J Allergy Asthma Immunol       Date:  2006-09       Impact factor: 1.464

Review 7.  Systemic corticosteroid therapy--side effects and their management.

Authors:  R M Stanbury; E M Graham
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

8.  Cellular mechanism of adrenalin stimulated chloride secretion via beta-adrenoceptor in T84 cells.

Authors:  Zi-Huan Yang; Ao Pan; Ye-Chun Ruan; Hai-Jie Yu; Zhong-Luan Wu; Hui Xiang; Wen-Liang Zhou
Journal:  Cell Biol Int       Date:  2008-02-03       Impact factor: 3.612

9.  Diagnosing cystic fibrosis--asthma and failure to thrive as indications for a sweat test.

Authors:  Dan Bar-Zohar; Danit Segal-Algranati; Amir Belson; Shimon Reif
Journal:  J Med       Date:  2004

10.  Epidemiology of asthma in India.

Authors:  H Paramesh
Journal:  Indian J Pediatr       Date:  2002-04       Impact factor: 1.967

View more
  2 in total

1.  Sweat chloride levels in asthma.

Authors:  Anirban Mandal; S K Kabra
Journal:  Indian J Pediatr       Date:  2014-12-28       Impact factor: 1.967

2.  Standardized clinical criteria and sweat test combined as a tool to diagnose Cystic Fibrosis.

Authors:  Fabricio González-Andrade
Journal:  Heliyon       Date:  2018-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.